2014
DOI: 10.1002/ijc.29168
|Get access via publisher |Cite
|
Sign up to set email alerts

"VSports最新版本" The sensitivity of gastric cancer to trastuzumab is regulated by the miR‐223/FBXW7 pathway

Abstract: A recent large-scale phase III study (the ToGA trial) demonstrated the significant efficacy of trastuzumab combined with chemotherapy in patients with HER2-positive gastric cancer. Although trastuzumab has become a key drug in cancer treatment, the resistance of breast cancer to trastuzumab is a major problem in clinical practice. However, it is unclear whether similar mechanisms of trastuzumab resistance are involved in gastric cancer (GC). The aim of the current study was to identify a novel micro-RNA (miR)/… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
69
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations

Cited by 89 publications

(74 citation statements)
references

References 38 publications

5
69
0
Order By: Relevance